The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Regulatory News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

9 Dec 2016 14:56

RNS Number : 4852R
ABCAM Plc
09 December 2016
 

For immediate release

9 December 2016

ABCAM PLC

("Abcam" or "the Company")

Non-Executive Director Remuneration

Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, has been notified that, each Non-Executive Director ("NED") purchased ordinary shares of 0.2 pence each in the Company ("Shares") on 8 December 2016 at a price of 785.8803 pence per share pursuant to individual fee agreements entered into by the NEDs with the Company on 15 October 2015 ("Fee Agreements") under which the NEDs agreed to receive part of their fees delivered as a fixed number of Shares.

 

Under the Fee Agreements, it was agreed that one third of the NEDs' initial total fees for Abcam's financial year ending 30 June 2016 would be delivered as Shares after deductions for PAYE and National Insurance following the announcement of the preliminary results for the year on 12 September 2016. As previously announced, a fixed number of Shares were calculated for each NED by dividing one third of the total fees by the average share price of £5.95 (being the average share price for the ten dealing days following the announcement of Abcam's preliminary results for the year ended 30 June 2015). A final reconciliation has now been completed and in order to satisfy the agreed one third of their total fee in Shares, the additional Shares detailed below have been purchased.

Details of the net number of Shares purchased and the total interest in the Company of each NED after the share purchase are set out below:

 

Non-Executive Director

Net number of Shares purchased

Total holding of Shares

Louise Patten

431

38,887

Mara Aspinall

298

1,048

Murray Hennessy

504

37,323

Susan Harris

428

1,615

 

Each of the NEDs has committed not to transfer or sell the Shares during the term of their Non-Executive directorship.

Michael Ross and Anthony Martin, who were Non-Executive Directors of the Company until 31 October 2016, received 78 and 220 Shares respectively 8 December 2016 in respect of their fees for Abcam's financial year ending 30 June 2016

For further information please contact:

Abcam

+ 44 (0) 1223 696 000

Suzanne Smith, Company Secretary

 

J.P.Morgan Cazenove - Nominated Adviser & Corporate Broker

+ 44 (0) 20 7742 4000

James Mitford / Chris Cargill

FTI Consulting

+ 44 (0) 20 3727 1000

Ben Atwell / Brett Pollard / Natalie Garland-Collins

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Louise Patten

2

Reason for the notification

a)

Position/status

Senior Independent Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

 

GB00B6774699

b)

Nature of the transaction

Purchase of shares pursuant to individual fee arrangements

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

7.858803

431

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

431

7.858803

3,387.14

f)

Date of the transaction

8 December 2016

g)

Place of the transaction

London Stock Exchange, AIM

 

 

 

 

 

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mara Aspinall

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

 

GB00B6774699

b)

Nature of the transaction

Purchase of shares pursuant to individual fee arrangements

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

7.858803

298

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

298

7.858803

2,341.92

f)

Date of the transaction

8 December 2016

g)

Place of the transaction

London Stock Exchange, AIM

 

 

 

 

 

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Murray Hennessy

2

Reason for the notification

a)

Position/status

Chairman

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

 

GB00B6774699

b)

Nature of the transaction

Purchase of shares pursuant to individual fee arrangements

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

7.858803

504

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

504

7.858803

3,960.83

f)

Date of the transaction

8 December 2016

g)

Place of the transaction

London Stock Exchange, AIM

 

 

 

 

 

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Susan Harris

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

 

GB00B6774699

b)

Nature of the transaction

Purchase of shares pursuant to individual fee arrangements

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

7.858803

428

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

428

7.858803

3,363.56

f)

Date of the transaction

8 December 2016

g)

Place of the transaction

London Stock Exchange, AIM

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHZKLFBQLFEFBX
Date   Source Headline
29th Oct 20212:42 pmRNSTotal Voting Rights
27th Oct 20217:00 amRNSCompletion of BioVision Acquisition
12th Oct 20214:46 pmRNSHolding(s) in Company
11th Oct 20214:21 pmRNSBlock listing Interim Review
6th Oct 202110:35 amRNSHolding(s) in Company
24th Sep 20214:03 pmRNSDirector/PDMR Shareholding
13th Sep 202112:00 pmRNSInterim results for the 6 and 12 month periods
1st Sep 20214:02 pmRNSTotal Voting Rights
1st Sep 202112:00 pmRNSTransition Report on 20-F and Notice of Results
17th Aug 20217:52 pmEQSThis is a test - Please ignore
13th Aug 20217:00 amRNSDirectorate Change
2nd Aug 202112:57 pmRNSTotal Voting Rights
2nd Aug 20217:00 amRNSAbcam to Acquire BioVision for $340 million
9th Jul 20212:34 pmRNSBlock listing Interim Review
1st Jul 20214:22 pmRNSTotal Voting Rights
1st Jul 20214:03 pmRNSResult of General Meeting
1st Jul 202112:00 pmRNSPre-Close Trading Update
2nd Jun 20219:54 amRNSTotal Voting Rights
2nd Jun 20218:30 amRNSNotice of Year End Change and General Meeting
19th May 20217:00 amRNSDirectorate Change
6th May 20217:00 amRNSTotal Voting Rights
1st Apr 20213:11 pmRNSTotal Voting Rights
12th Mar 20212:55 pmRNSDirector/PDMR Shareholding
11th Mar 202111:46 amRNSDirector/PDMR Shareholding - Replacement
10th Mar 20214:50 pmRNSDirector/PDMR Shareholding
8th Mar 202112:02 pmRNSInterim Results for 6 months ended 31 Dec 2020
1st Mar 20215:08 pmRNSTotal Voting Rights
26th Feb 20217:00 amRNSNotice of Results
17th Feb 202112:00 pmRNSAbcam presenting at the SVB Leerink Conference
4th Feb 20213:24 pmRNSDirector/PDMR Shareholding
1st Feb 20219:27 amRNSTotal Voting Rights
28th Jan 20217:00 amRNSDirectorate Change
14th Jan 20213:26 pmRNSHolding(s) in Company
11th Jan 202112:00 pmRNSHalf year trading update
4th Jan 202111:03 amRNSTotal Voting Rights
21st Dec 20207:00 amRNSAbcam plc presenting at JPM Healthcare Conference
21st Dec 20207:00 amRNSNotification of Trading Update
17th Dec 20209:35 amRNSHolding(s) in Company
4th Dec 20202:32 pmRNSResult of AGM
1st Dec 20204:46 pmRNSTotal Voting Rights
4th Nov 202010:33 amRNSDirector/PDMR Shareholding
3rd Nov 20201:30 pmRNSAnnual Report, Impact Report and Notice of AGM
3rd Nov 20201:30 pmRNSConsultation on 2020 LTIP Awards
2nd Nov 202010:49 amRNSTotal Voting Rights
26th Oct 20203:45 pmRNSAbcam Announces Closing of Offering
23rd Oct 20207:00 amRNSExercise of Over-allotment Option
22nd Oct 20207:00 amRNSPricing of Offering on NASDAQ
19th Oct 202012:15 pmRNSOffering and Application to List on Nasdaq
5th Oct 20207:01 amRNSRegistration Statement for Proposed Offering Filed
5th Oct 20207:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.